BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10443516)

  • 1. Effects of defibrillator implantation testing on myocardial metabolism.
    Wolfhard U; Knocks M; Splittgerber FH; Sack S; Piotrowski JA; Günnicker M
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):157-61. PubMed ID: 10443516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial lactate extraction during repeated fibrillation/defibrillation episodes in defibrillator implantation testing.
    Wolfhard UF; Brinkmann M; Splittgerber FH; Knocks M; Sack S; Piotrowski JA; Schieffer M; Günnicker M
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1795-801. PubMed ID: 9744445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transient myocardial ischemia on the ventricular defibrillation threshold.
    Anastasiou-Nana MI; Tsagalou EP; Charitos C; Siafakas KX; Drakos S; Terrovitis JV; Ntalianis A; Doufas A; Mavrikakis J; Nanas JN
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):97-101. PubMed ID: 15679638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolism and ventricular function following cold potassium cardioplegia.
    Fremes SE; Weisel RD; Mickle DA; Ivanov J; Madonik MM; Seawright SJ; Houle S; McLaughlin PR; Baird RJ
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):531-46. PubMed ID: 3872382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral ischemia during implantation of automatic defibrillators].
    Behrens S; Spies C; Neumann U; Ehlers C; Kraemer S; Brüggemann T; Andresen D
    Z Kardiol; 1995 Oct; 84(10):798-807. PubMed ID: 7502566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads.
    Rosenheck S; Sharon Z; Weiss A
    Cardiology; 2009; 112(2):107-13. PubMed ID: 18583908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrillation threshold testing and neurologic outcome.
    Karaoğuz R
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():47-9. PubMed ID: 17584679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest.
    Stiell IG; Walker RG; Nesbitt LP; Chapman FW; Cousineau D; Christenson J; Bradford P; Sookram S; Berringer R; Lank P; Wells GA
    Circulation; 2007 Mar; 115(12):1511-7. PubMed ID: 17353443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of atrial pacing test for survival of patients with coronary artery disease.
    Dagenais GR; Cornaert P; Rouleau JR; Dumesnil JG; Christen A; Marquis Y; Moisan A
    Clin Invest Med; 1983; 6(4):247-52. PubMed ID: 6671355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ventricular fibrillation in chronic heart disease].
    Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
    Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in human coronary sinus blood flow and myocardial metabolism induced by ventricular fibrillation and defibrillation.
    Runsiö M; Bergfeldt L; Rosenqvist M; Owall A; Jorfeldt L
    J Cardiothorac Vasc Anesth; 1998 Feb; 12(1):45-50. PubMed ID: 9509356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.